Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation

Conditions

• Gestational Diabetes

Interventions

• DRUG: 500 mg of ursodeoxycholic acid (UDCA)
• OTHER: 500 mg of Placebo

Sponsor

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia